PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Equity / COM NEW
Total 13F shares
1,972,774
Share change
+244,003
Total reported value
$7,929,020
Put/Call ratio
128%
Price per share
$4.02
Number of holders
23
Value change
+$998,681
Number of buys
15
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q2 2017

As of 30 Jun 2017, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,972,774 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, Aisling Capital LLC, BlackRock Inc., Virtu KCG Holdings LLC, Cetera Investment Advisers, GEODE CAPITAL MANAGEMENT, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, and MORGAN STANLEY. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.